Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Prominent San Diego Dermatologist and Cosmetic Surgeon Dr. Mitchel P. Goldman Discusses Treatment of Vitiligo and Psoriasis with New Excimer Skin Laser
  • USA - English


News provided by

Goldman Marketing Group

Sep 06, 2017, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Mitchel Goldman, board-certified dermatologist, Medical Director of West Dermatology California, and founder of Cosmetic Laser Dermatology in San Diego, CA.
Dr. Mitchel Goldman, board-certified dermatologist, Medical Director of West Dermatology California, and founder of Cosmetic Laser Dermatology in San Diego, CA.

"For patients with vitiligo or psoriasis, Excimer laser treatment may be the procedure they’ve been looking for," said. Dr. Goldman

Post this

San Diego, CA (PRWEB) September 06, 2017 -- The American Academy of Dermatology states that more than seven million Americans are afflicted with vitiligo, a skin disorder characterized by the formation of lighter-colored patches of skin due to the loss of skin pigment cells called melanocytes. It’s also thought that another eight million Americans have psoriasis, a chronic disease of the immune system that results in thick, flaky, inflamed patches of skin. While no cure is guaranteed for either disorder, Cosmetic Laser Dermatology have recently acquired the Excimer laser, which is one of the most effective treatments for managing both conditions.

“Both vitiligo and psoriasis affect one’s appearance,” says Dr. Goldman, board-certified dermatologist, Medical Director of West Dermatology California, and founder of Cosmetic Laser Dermatology in San Diego, CA. “Each condition can have an adverse impact on one’s self-esteem, which is exacerbated by the fact that neither condition has a known cure. Traditionally, both vitiligo and psoriasis have been managed with a variety of topical treatments, oral medications, or light therapy. However, we believe that there is one treatment option that is effective for both – the Excimer laser, which is a new service at our practice.”

The PHAROS EX-308 Excimer laser delivers ultraviolet light at a specific wavelength (308 nanometers) that has been found to help improve the skin. For vitiligo, it helps the skin regain its normal pigmentation more quickly while for psoriasis, it helps clear the skin more effectively and quickly. In fact, because the Excimer laser features intense, very focused doses of controlled UVB light that penetrate deep without harming the surrounding healthy skin, it is particularly effective for dark-skinned vitiligo sufferers. It’s also very effective for psoriasis that has developed in hard-to-reach areas of the body, such as the scalp, elbow, palms, knees, and soles of the feet.

“The Excimer laser is similar to traditional light therapy treatments, but there is a difference,” Dr. Goldman says. “Because it delivers light energy at a precise 308 nm, it penetrates better and deeper in a shorter period of time, which usually means fewer sessions and a quicker return for patients to their normal appearance. For even better results, we use it with a topical calcineurin inhibitor, such as topical tacalcitol, which also results in safer, faster treatments.”

Cosmetic Laser Dermatology and its sister practice, West Dermatology & Skin Cancer Center, located just across the hall from each other in the UTC area of San Diego, now offer the PHAROS EX-308 Excimer laser treatment option for its patients. The treatment is split 50:50 between the two practices, with Dr. Stacy D. Tompkins and Dr. Brook Brouha (West Dermatology) and Leysin Fletcher, PA-C (Cosmetic Laser Dermatology), expertly administering the therapy. To learn more about both vitiligo and psoriasis, as well as more about the Excimer laser, visit http://www.CLDerm.com.

“We’re excited about this joint initiative between the two practices,” Dr. Goldman says. “Dr. Tompkins, Dr. Brouha, and Ms. Fletcher are highly skilled and extensively trained in the use of the Excimer laser, ensuring that patients receive the safest, most effective treatment possible to manage both of these two debilitating skin conditions. For patients with vitiligo or psoriasis, Excimer laser treatment may be the procedure they’ve been looking for, though it’s important to keep in mind that there is no guaranteed cure for either. Still, this treatment might give many patients peace of mind.”

Cosmetic Laser Dermatology is an esteemed cosmetic clinic located in beautiful San Diego, California and a member of the West Dermatology network. The team of board-certified dermatologists is committed to providing each and every patient with the highest level of care in a comfortable setting. Cosmetic Laser Dermatology’s dermatologists are all highly respected in the field for their use of innovative treatments, involvement in advanced medical research, and continued participation in clinical trials.

For more information please visit http://www.CLDerm.com

Cosmetic Laser Dermatology
9339 Genesee Ave #300,
San Diego, CA 92121
(858) 943-2113
inquiries(at)CLDerm(dot)com

Risa Goldman, Goldman Marketing Group, +1 818-861-7092, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.